LISATA THERAPEUTICS, INC. Employee-related Liabilities
LISATA THERAPEUTICS, INC. (LSTA) had Employee-related Liabilities of $2.67 million as of 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities › Accrued Liabilities
us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent · last filed 2024-02-29
- 2023-12-31: Employee-related Liabilities $2.67M.
- 2022-12-31: Employee-related Liabilities $2.59M.
- 2021-12-31: Employee-related Liabilities $2.03M.
- 2020-12-31: Employee-related Liabilities $1.72M.
| Period end | Employee-related Liabilities | Employee-related Liabilities as first filed |
|---|---|---|
| 2023-12-31 | $2.67M 10-K · filed 2024-02-29 | |
| 2022-12-31 | $2.59M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $2.03M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $1.72M 10-K · filed 2022-03-22 | |
| 2019-12-31 | $1.83M 10-K · filed 2021-02-25 | |
| 2019-06-30 | $1.29M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $908.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.76M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $1.38M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.42M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $666.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.39M 10-K · filed 2019-03-14 | $1.39M 10-K · filed 2018-03-22 |
| 2017-09-30 | $1.17M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.13M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $2.76M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $1.41M 10-K · filed 2018-03-22 | $4.21M 10-K · filed 2017-03-17 |
| 2016-09-30 | $4.09M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $3.16M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $3.15M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $2.77M 10-K · filed 2017-03-17 | $2.77K 10-K · filed 2016-03-15 |
| 2015-09-30 | $3.83M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $3.46M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $3.34M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $2.81K 10-K · filed 2016-03-15 | |
| 2014-09-30 | $1.44M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $1.44K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $846.40 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $2.33K 10-K · filed 2015-03-02 | |
| 2013-09-30 | $920.80 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $951.80 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $838.70 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $1.60K 10-K · filed 2014-03-13 | |
| 2011-12-31 | $365.70 10-K · filed 2013-03-11 | $365.70K 8-K · filed 2012-08-15 |
| 2010-12-31 | $85.40K 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |